TMAN Pharmaceutical is pivoting toward "Longevity" as a new growth engine, launching Heaven Herb factory in Pathum Thani (100M baht annual Smart Factory investment) and expanding its health & wellness portfolio with 15 science-backed products targeting metabolism, gut, brain, sleep, and skin over the next 5 years. The Longevity segment is projected to contribute 5–10% of revenue, with total group revenue targeting 4 billion baht by 2026. Flagship product Propoliz is being aggressively expanded into 7 countries (China, Hong Kong, Malaysia, Laos, Myanmar, and newly South Korea and Indonesia), positioning TMAN to capture Thailand's booming wellness market (forecast to grow 8.5% annually to USD 61.4 billion by 2032).